The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Absolute lymphocyte count (ALC) during and after chemoradiation (CRT) for squamous cell carcinoma of the head and neck (SCCHN): Effect of the regimen and potential therapeutic implications.
 
Marit Uglane
No Relationships to Disclose
 
Shalin Shah
No Relationships to Disclose
 
Arif Shaikh
No Relationships to Disclose
 
Nicholas Campbell
No Relationships to Disclose
 
Mihir Bhayani
No Relationships to Disclose
 
Everett E. Vokes
Stock and Other Ownership Interests - McKesson
Consulting or Advisory Role - Abbvie; Amgen; ARIAD; AstraZeneca; Bayer; Biolumina; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; EMD Serono; Genentech; Leidos Biomedical Research; Lilly; Merck; Novartis; Regeneron; Takeda; VentiRx
 
Ranjeev Nanda
No Relationships to Disclose
 
Vathsala T. Raghavan
No Relationships to Disclose
 
Bruce Brockstein
Consulting or Advisory Role - Blueprint Medicines
Research Funding - AstraZeneca (Inst)
Patents, Royalties, Other Intellectual Property - UpToDate. Author and Editorial dutues
Expert Testimony - Pfizer